2019
DOI: 10.1038/s41598-019-49438-w
|View full text |Cite
|
Sign up to set email alerts
|

Identification of in vivo nonlinear anisotropic mechanical properties of ascending thoracic aortic aneurysm from patient-specific CT scans

Abstract: Accurate identification of in vivo nonlinear, anisotropic mechanical properties of the aortic wall of individual patients remains to be one of the critical challenges in the field of cardiovascular biomechanics. Since only the physiologically loaded states of the aorta are given from in vivo clinical images, inverse approaches, which take into account of the unloaded configuration, are needed for in vivo material parameter identification. Existing inverse methods are computationally expensive, which take days … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
30
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 32 publications
(30 citation statements)
references
References 48 publications
0
30
0
Order By: Relevance
“…The areas under the curves (AUC), which reflect the discriminative powers of the failure metrics, are 0.5489, 0.8448, 0.7644 and 0.8621, respectively, for Method 1~ Method 4. The diameter criterion has the lowest AUC, while the highest AUC is achieved by FP evaluated under elevated blood pressure using the patient-specific hyperelastic properties, which highlights the potential benefits of incorporating patient-specific hyperelastic properties[53][54][55][56][57][58] in the risk stratification. specific hyperelastic properties, the performance is not improved by evaluating FP under elevated blood pressure by using a representative set of hyperelastic parameters.In general, to evaluate a diagnostic method, an AUC of 0.5 suggests no discrimination, 0.7 to 0.8 is considered acceptable, and 0.8 to 0.9 is considered excellent[59].…”
mentioning
confidence: 88%
“…The areas under the curves (AUC), which reflect the discriminative powers of the failure metrics, are 0.5489, 0.8448, 0.7644 and 0.8621, respectively, for Method 1~ Method 4. The diameter criterion has the lowest AUC, while the highest AUC is achieved by FP evaluated under elevated blood pressure using the patient-specific hyperelastic properties, which highlights the potential benefits of incorporating patient-specific hyperelastic properties[53][54][55][56][57][58] in the risk stratification. specific hyperelastic properties, the performance is not improved by evaluating FP under elevated blood pressure by using a representative set of hyperelastic parameters.In general, to evaluate a diagnostic method, an AUC of 0.5 suggests no discrimination, 0.7 to 0.8 is considered acceptable, and 0.8 to 0.9 is considered excellent[59].…”
mentioning
confidence: 88%
“…Therefore, medical images obtained from various imaging modalities have been combined with inverse FEA to derive in vivo vascular mechanical properties. For example, the in vivo aortic elastic properties of ascending thoracic aortic aneurysm have been identified from gated CT scans using an inverse approach ( Liu et al, 2019a ). An iterative procedure has also been developed to identify coronary artery mechanical properties by matching both maximum and minimum in vivo Cine IVUS lumen circumferences ( Guo et al, 2017 ; Wang et al, 2021 ).…”
Section: Pipeline Of Image-based Computational Biomechanical Simulationsmentioning
confidence: 99%
“…Before closing this article, let us emphasize that it is unclear whether the results of in-vitro experimentation on ATAA tissue are representative of the in-vivo failure modes. There have been recent attempts to assess the in-vivo mechanical properties of ATAAs, 50,51 but tissue strength can only be determined through destructive in-vitro testing. Until this obstacle is obviated by noninvasive strength determination, use of clinically measurable parameters as surrogate measures of aortic tissue strength may help to assess the risks of aortic complications based on solely noninvasive clinical data.…”
Section: Future Directionsmentioning
confidence: 99%